| Literature DB >> 35511485 |
Shizuka Watanabe1,2, Koichi Kobayashi1,2,3, Maho Suzukawa1, Sayaka Igarashi1, Kazufumi Takada1,4, Sahoko Imoto1,2, Masashi Kitani5, Takeshi Fukami6, Takahide Nagase2, Ken Ohta1,7.
Abstract
Secretory immunoglobulin A plays an important role in the protection against exogenous pathogens and antigens, but it has also been reported to have pathogenic potential. We previously found that secretory immunoglobulin A accumulated in the peripheral lungs during idiopathic pulmonary fibrosis and that transferrin receptor/CD71 was partially involved in secretory immunoglobulin A-induced inflammatory cytokine production in A549 cells. This study aimed to identify the receptor responsible for the induction of cytokine production by secretory immunoglobulin A-stimulated airway epithelial cells. To this end, immunoprecipitation followed by time-of-flight mass spectrometry and peptide mass fingerprinting were performed and Annexin A2 was detected as a novel receptor for secretory immunoglobulin A. Enzyme-linked immunosorbent assay demonstrated binding of secretory immunoglobulin A to Annexin A2, and flow cytometry showed robust expression of Annexin A2 on the surface of BEAS-2B cells, A549 cells, and normal human bronchial/tracheal epithelial cells. Experiments in A549 cells using Annexin A2 small interfering RNA and neutralizing antibodies suggested that Annexin A2 was partially involved in the production of interleukin-8/CXCL8 and C-C motif chemokine ligand 2/monocyte chemoattractant protein-1 induced by secretory immunoglobulin A. Immunohistochemistry using lung sections revealed clear expression of Annexin A2 on airway epithelial cells, although the staining remained equivalent in idiopathic pulmonary fibrosis, asthma, and healthy control lungs. In conclusion, we identified that Annexin A2 expressed in airway epithelial cells is a novel receptor for secretory immunoglobulin A, which is involved in cytokine synthesis.Entities:
Keywords: Annexin A2; cytokine; epithelial cell; immunoglobulin A; receptor
Mesh:
Substances:
Year: 2022 PMID: 35511485 PMCID: PMC9226145 DOI: 10.1093/cei/uxac043
Source DB: PubMed Journal: Clin Exp Immunol ISSN: 0009-9104 Impact factor: 5.732